共 11 条
[1]
Pharmacological blockade or genetic deletion of substance P ( NK1 ) receptors attenuates neonatal vocalisation in guinea -pigs and mice. Rupniak NM,Carlson EC,Harrison T,et al. Neuropharmacology . 2000
[2]
Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Kramer MS,Cutler N,Feighner J,et al. Science . 1998
[3]
Substance P( NK1 ) redeptors in the cingulate cortex in unipolar and biopolar mood disorder and schizophrenia. Burnet PW,Harrison PJ. Biological Psychiatry . 2000
[4]
Neuroanatomical localisation of substance P in the CNS and sensory neurons. Ribeiro -da -Silva A,Hokfelt T. Neuropeptides . 2000
[5]
Discovery of the antidepressant and anti emetic efficacy of substance P receptor( NK1 ) antagonists. Rupniak NM,Kramer MS. Trends in Pharmacological Sciences . 1999
[6]
Imaging substance P receptors( NK1 ) in the living human brain using positron emission tomography. Richard Hargreaves. Journal of Clinical Psychiatry . 2002
[7]
Effects of the neuropeptides substance P on sleep, mood, and neuroendocrine measures in healthy young men. Lieb K,Ahlvers K,Dancker K,et al. Neuropsychopharmacology . 2002
[8]
The tachykinin NK1 receptor in the brain: pharmacology and putative functions. Saria A. European Journal of Pharmacology . 1999
[9]
Demonstration of the efficacy and safety of a novel substance P ( NK1 ) receptor antagonist in major depression. Kramer MS,Winokur A,Kelsey J,et al. Neuropsychopharmacology . 2004
[10]
Comparison of the phenotype of NK1 R -/ -mice with pharmacological blockade of the substance P( NK1 ) receptor in assays for antidepressant and anxiolytic drugs. Rupniak N MJ,Carlson EJ,Webb JK,et al. Behavioural Pharmacology . 2001